LUCINACTANT

Search structure
Trade Names:
Synonyms:
Status: Approved (2012)
Entry Type: Unknown
Molecule Category: UNKNOWN
UNII: 5BSH2G9BH8

Pharmacology

Action Mechanism of Action Reference
None Surfactant agent FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Meconium Aspiration Syndrome 3 D008471 ClinicalTrials
Respiratory Distress Syndrome 2 D012128 ClinicalTrials
Cystic Fibrosis 2 D003550 ClinicalTrials
Respiratory Distress Syndrome, Newborn 2 D012127 ClinicalTrials
Respiratory Insufficiency 2 D012131 ClinicalTrials

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Respiratory, thoracic and mediastinal disorders
43.75
Vascular disorders
12.5
Pregnancy, puerperium and perinatal conditions
9.38
Investigations
6.25
Metabolism and nutrition disorders
6.25
Nervous system disorders
6.25
Cardiac disorders
3.12
Congenital, familial and genetic disorders
3.12
General disorders and administration site conditions
3.12
Hepatobiliary disorders
3.12
Renal and urinary disorders
3.12

Cross References

Resources Reference
CAS NUMBER 825600-90-6
ChEMBL CHEMBL1963685
FDA SRS 5BSH2G9BH8
CONTENTS